Lung Cancer Treatment Drug Tarceva Makes the Disease Possible To Treat

The drug Tarceva, made by OSI Pharmaceuticals has been found to cause an increase in survival rates in lung cancer patients when the drug is administered after chemotherapy treatments. The chief executive officer of the company, Colin Goddard, was pleased to announce the results. This drug may be the first in a wave of new treatments for cancer.

This drug works by stopping the growth of non small cell cancer cells, which then slows and even eliminates the cancer?s spread throughout the body. The study involved 889 patients who were given at least four cycles chemotherapy and were then treated with either once-daily Tarceva or a placebo if the disease did not progress during chemotherapy.

Read the rest of this entry »

Cough medicine ingredient may treat prostate cancer

NEW YORK (Reuters Health) - Noscapine, a natural substance found in cough medicine, may prove useful in treating advanced prostate cancer, according to studies in mice.

Researchers found that noscapine — a non-addictive derivative of opium — reduced tumor growth in mice by 60 percent and limited the spread of tumors by 65 percent without causing harmful side effects.

Dr. Israel Barken, of The Prostate Cancer Research and Education Foundation, La Mesa, California, and colleagues report their finding in the journal Anticancer Research.

Read the rest of this entry »